Diabetic Ketoacidosis News and Research

RSS
Diabetic ketoacidosis – (DKA) or diabetic coma occurs when a diabetic does not properly balance their insulin intake with their diet or activity.
3U researchers discover biological marker that could predict development of Type 1 diabetes

3U researchers discover biological marker that could predict development of Type 1 diabetes

Study finds reduction in HbA1c levels with in-home use of hybrid closed-loop insulin delivery system

Study finds reduction in HbA1c levels with in-home use of hybrid closed-loop insulin delivery system

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

Detecting diabetes’ deadly ketones

Detecting diabetes’ deadly ketones

Triple therapy approach helps Type 1 diabetes patients improve blood sugar control, lose weight

Triple therapy approach helps Type 1 diabetes patients improve blood sugar control, lose weight

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Integrated treatment required for diabetes-eating disorder combination

Integrated treatment required for diabetes-eating disorder combination

LixiLan-O Phase III clinical trial meets primary endpoint in patients with type 2 diabetes

LixiLan-O Phase III clinical trial meets primary endpoint in patients with type 2 diabetes

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Treatment outcomes in type 1 diabetes could be improved across all age groups

Treatment outcomes in type 1 diabetes could be improved across all age groups

Incidence of potentially life-threatening diabetes complication increasing among youth in Colorado

Incidence of potentially life-threatening diabetes complication increasing among youth in Colorado